http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014088417-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2014-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_759fbbb3ca370ce8ca270ed318cf03d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8929982910021e76774179a059fcdbbd
publicationDate 2014-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2014088417-A
titleOfInvention Deferasirox dispersible tablets
abstract Disclosed is a dispersible tablet that is easy to administer to adults and children who require repeated blood transfusions and provides a daily dose of pharmacological activity. 4- [3,5-bis (2-hydroxyphenyl)-[1,2,4] triazol-1-yl] benzoic acid is a crystalline and free acid form effective as an iron chelator A dispersible tablet comprising (formula below) or a pharmaceutically acceptable salt thereof in an amount of 5 to 40% by weight of the total weight of the tablet. [Selection figure] None
priorityDate 2002-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0245416-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000273045-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02129124-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000507601-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412714967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136441184

Total number of triples: 38.